Accuray Inc. (ARAY) Company Cash on Hand

High patent barriers and the complexity of physician training create a durable moat for Accuray Incorporated (ARAY). Free cash flow levels demonstrate the liquidity of the business, with the latest parameter standing at 0.04. Stability is underpinned by global reach and service contracts, while the primary capital is generated by sales of CyberKnife robotic systems to leading oncology centers.
Accuray (ARAY) - metric breakdowns and financial figures

Accuray Incorporated (ARAY) focuses on the expansion of CyberKnife systems and the integration of AI into radiation therapy. By analyzing changes in cash asset volume, an investor assesses the liquid reserve available for scaling the business without incurring external debt. This metric reflects the balance between operational resilience and capital efficiency. A stable cash level confirms the company's ability to fund technological modernization and expansion into emerging markets.